How ADCs Are Transforming Cancer Treatment
Antibody Drug Conjugates (ADCs) are revolutionizing cancer treatment by combining targeted monoclonal antibodies with potent cytotoxic agents to specifically destroy cancer cells while sparing healthy tissues. The expanding therapeutic potential and growing global market for ADCs are driven by technological advancements, strategic partnerships, and a rising demand for precision medicine, promising significant progress in oncology […]
3 minute read